Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.06% is 118% above its 5-year average of 0.49%, near the high end of its 5-year range (0.01%–1.18%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.02% above its 12-month average of 0.91%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.06%.
DEBT TO ASSETS RATIO
1.06%
DEBT TO ASSETS RATIO AVG TTM
0.91%
DEBT TO ASSETS RATIO AVG 3Y
0.61%
DEBT TO ASSETS RATIO AVG 5Y
0.49%
DEBT TO ASSETS RATIO AVG 10Y
0.41%
DEBT TO ASSETS RATIO AVG 15Y
1.51%
DEBT TO ASSETS RATIO AVG 20Y
0.32%
CURRENT VS TTM AVG
+16.02%
CURRENT VS 3Y AVG
+72.46%
CURRENT VS 5Y AVG
+117.52%
CURRENT VS 10Y AVG
+156.15%
CURRENT VS 15Y AVG
-29.58%
CURRENT VS 20Y AVG
+227.84%
SECTOR MEDIAN · HEALTHCARE
0.13%
median of 374 covered companies
CURRENT VS SECTOR MEDIAN
+715.45%
vs the sector median at left
Corcept Therapeutics Incorporated
Market Cap
$13.19B
Debt to Assets Ratio
1.06%
TTM Avg
0.91%
3Y Avg
0.61%
5Y Avg
0.49%
Market Cap
$12.95B
Debt to Assets Ratio
2.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.89B
Debt to Assets Ratio
0.21%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.52B
Debt to Assets Ratio
0.49%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.16B
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.17B
Debt to Assets Ratio
0.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.00B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corcept Therapeutics Incorporated (CORT) | $13.19B | 1.06% | 0.91% | 0.61% | 0.49% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | 2.05% | N/A | N/A | N/A |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 0.21% | N/A | N/A | N/A |
| Baxter International Inc. (BAX)vs › | $12.52B | 0.49% | N/A | N/A | N/A |
| Penumbra, Inc. (PEN)vs › | $12.49B | 0.11% | N/A | N/A | N/A |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | 0.20% | N/A | N/A | N/A |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 0.40% | N/A | N/A | N/A |
| Encompass Health Corporation (EHC)vs › | $12.00B | 0.38% | N/A | N/A | N/A |
| Tempus AI, Inc. (TEM)vs › | $14.64B | 0.61% | N/A | N/A | N/A |
| Exelixis, Inc. (EXEL)vs › | $14.79B | 0.07% | N/A | N/A | N/A |
Debt/Assets
1.1%
Debt/Equity
0.01
Current Ratio
2.86
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.06% |
| 2026-03-31 | 1.18% |
| 2025-12-31 | 0.73% |
| 2025-09-30 | 0.77% |
| 2025-06-30 | 0.82% |
| 2025-03-31 | 0.81% |
| 2024-12-31 | 0.83% |
| 2024-09-30 | 0.87% |
| 2024-06-30 | 0.79% |
| 2024-03-31 | 0.01% |
| 2023-12-31 | 0.02% |
| 2023-09-30 | 0.04% |
| 2023-06-30 | 0.06% |
| 2023-03-31 | 0.09% |
| 2022-12-31 | 0.20% |
| 2022-09-30 | 0.32% |
| 2022-06-30 | 0.46% |
| 2022-03-31 | 0.60% |
| 2021-12-31 | 0.12% |
| 2021-09-30 | 0.18% |
| 2021-06-30 | 0.27% |
| 2021-03-31 | 0.37% |
| 2020-12-31 | 0.45% |
| 2020-09-30 | 0.57% |
| 2020-06-30 | 0.70% |
| 2020-03-31 | 0.70% |
| 2019-12-31 | 0.84% |
| 2019-09-30 | 0.21% |
| 2019-06-30 | 0.35% |
| 2019-03-31 | 0.47% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 5.28% |
| 2017-03-31 | 13.42% |
| 2016-12-31 | 21.33% |
| 2016-09-30 | 29.76% |
| 2016-06-30 | 39.24% |
| 2016-03-31 | 30.85% |
| 2015-12-31 | 28.81% |
| 2015-09-30 | 27.92% |
| 2015-06-30 | 24.89% |
| 2015-03-31 | 22.10% |
| 2014-12-31 | 27.21% |
| 2014-09-30 | 23.31% |
| 2014-06-30 | 16.66% |
| 2014-03-31 | 13.05% |
| 2013-12-31 | 9.10% |
| 2013-09-30 | 6.33% |
| 2013-06-30 | 4.58% |
| 2013-03-31 | 4.42% |
| 2012-12-31 | 2.67% |
| 2012-09-30 | 28.97% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.02% |
| 2009-12-31 | 0.02% |
| 2009-09-30 | 0.08% |
| 2009-06-30 | 0.08% |
| 2009-03-31 | 0.07% |
| 2008-12-31 | 0.08% |
| 2008-09-30 | 0.08% |
| 2008-06-30 | 0.08% |
| 2008-03-31 | 0.08% |
| 2007-12-31 | 0.16% |
| 2007-09-30 | 0.16% |
| 2007-06-30 | 0.27% |
| 2007-03-31 | 0.26% |
| 2006-12-31 | 0.42% |
| 2006-09-30 | 0.36% |
| 2006-06-30 | 0.26% |
| 2006-03-31 | 0.20% |
| 2005-12-31 | 0.18% |
| 2005-09-30 | 0.13% |
| 2005-06-30 | 0.03% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 5.14% |
| 2003-12-31 | 4.45% |
